Literature DB >> 17697795

Effect of recovery intensity on peak power output and the development of heat strain during intermittent sprint exercise while under heat stress.

Neil S Maxwell1, Paul C Castle, Matt Spencer.   

Abstract

This study compared two intensities of active recovery on intermittent sprint exercise performance and the development of heat strain in hot, humid conditions. Eight male game players completed four Cycling Intermittent Sprint Protocols (CISP) consisting of twenty 2-min periods, each including 10-s passive rest, 5-s maximal sprint against a resistance of 7.5% body mass and 105-s active recovery. The CISP was performed in mean (S.D.) temperate conditions with active recovery intensities of 50% V(O)(2peak) (TEMP50) and 35% V(O)(2peak)(TEMP35) and in hot, humid [35.2 (0.4) degrees C, 80.4 (2.1)% RH] conditions with the same intensities (HOT50 and HOT35, respectively) in a randomised, counterbalanced order. Heat strain (physiological strain index (PSI)) was calculated from rectal temperature and heart rate. All subjects completed the CISP (20 sprints) in TEMP50 and TEMP35. The mean number of sprints completed for HOT50 and HOT35 was 13 (3) and 17 (2), respectively; both of which were lower than TEMP50 and TEMP35 (P<0.01) and different between hot conditions. Reductions in peak power output (PPO) occurred in the TEMP50 and HOT50 by sprint 8 (P<0.05), but in HOT35 a reduction was delayed until sprint 13 (P<0.05). The rate of PSI increase was faster in HOT50 than TEMP50 and HOT35, but peak PSI was not different. By lowering the recovery intensity, one component of the PSI (heart rate) was reduced and intermittent sprint exercise performance was maintained for longer in the heat.

Mesh:

Year:  2007        PMID: 17697795     DOI: 10.1016/j.jsams.2007.05.008

Source DB:  PubMed          Journal:  J Sci Med Sport        ISSN: 1878-1861            Impact factor:   4.319


  1 in total

1.  Heat stress and physical capacity: a case study of semi-professional footballers.

Authors:  Farideh Golbabaei; Seyyed Abolfazl Zakerian; Behzad Fouladi Dehaghi; Leila Ibrahimi Ghavamabadi; Framarz Gharagozlou; Mostafa Mirzaei Aliabadi; Rasol Hematjo
Journal:  Iran J Public Health       Date:  2014-03       Impact factor: 1.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.